Tapewire

NYSE · USD

INSP

Inspire Medical Systems, Inc.

Export transactions ↓
Tapewire entity
1186
SEC CIK
0001609550
Parsed reports
589

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 30, 2024 Filed Feb 1, 2024 01:40 UTC
Jandrich StevenVP, Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 16,225 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001104659-24-008980 · tm244813-2_4seq1.xml · derivative · entry 4

Jandrich Steven · CIK 0001737203 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,100

Underlying: Common Stock · 16,225 shares

Expires 2027-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
January 30, 2024 Filed Feb 1, 2024 01:40 UTC
Jandrich StevenVP, Human Resources
Exercise / conversionCommon Stock 16,225 $0.94 $15,251.50
Disclosure

SEC source: 0001104659-24-008980 · tm244813-2_4seq1.xml · nonDerivative · entry 1

Jandrich Steven · CIK 0001737203 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,096

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 01:48 UTC
Phillips Bryan KSee Remarks
Tax withholdingCommon Stock 205 $216.61 $44,405.05
Disclosure

SEC source: 0001104659-24-008988 · tm244813-1_4seq1.xml · nonDerivative · entry 1

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,877

F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

F2 · balance_after: Includes (i) 44 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan (the "Plan") on December 31, 2021, (ii) 35 shares acquired under the Company Plan on June 30, 2023 and (iii) 43 shares acquired under the Company Plan on December 31, 2023.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:48 UTC GrantCommon Stock 80 $186.10 $14,888.00
Disclosure

SEC source: 0001104659-24-004911 · tm243653-6_4seq1.xml · nonDerivative · entry 3

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,330

F3 · shares: Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:48 UTC GrantCommon Stock 8 $150.47 $1,203.76
Disclosure

SEC source: 0001104659-24-004911 · tm243653-6_4seq1.xml · nonDerivative · entry 2

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:48 UTC GrantCommon Stock 2 $325.91 $651.82
Disclosure

SEC source: 0001104659-24-004911 · tm243653-6_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,242

F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:46 UTC GrantCommon Stock 87 $186.10 $16,190.70
Disclosure

SEC source: 0001104659-24-004909 · tm243653-4_4seq1.xml · nonDerivative · entry 3

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,234

F3 · shares: Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:46 UTC GrantCommon Stock 8 $150.47 $1,203.76
Disclosure

SEC source: 0001104659-24-004909 · tm243653-4_4seq1.xml · nonDerivative · entry 2

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,147

F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:46 UTC GrantCommon Stock 2 $325.91 $651.82
Disclosure

SEC source: 0001104659-24-004909 · tm243653-4_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,139

F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:47 UTC GrantCommon Stock 134 $186.10 $24,937.40
Disclosure

SEC source: 0001104659-24-004910 · tm243653-5_4seq1.xml · nonDerivative · entry 3

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,267

F3 · shares: Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:47 UTC GrantCommon Stock 25 $150.47 $3,761.75
Disclosure

SEC source: 0001104659-24-004910 · tm243653-5_4seq1.xml · nonDerivative · entry 2

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,133

F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:47 UTC GrantCommon Stock 8 $325.91 $2,607.28
Disclosure

SEC source: 0001104659-24-004910 · tm243653-5_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,108

F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:43 UTC GrantCommon Stock 77 $186.10 $14,329.70
Disclosure

SEC source: 0001104659-24-004906 · tm243653-1_4seq1.xml · nonDerivative · entry 7

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,482

F5 · shares: Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:43 UTC GrantCommon Stock 8 $150.47 $1,203.76
Disclosure

SEC source: 0001104659-24-004906 · tm243653-1_4seq1.xml · nonDerivative · entry 6

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,405

F4 · shares: Represents settlement of shares of Common Stock issued in lieu of cash fees to which the Reporting Person was previously granted pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023 and inadvertently not previously issued due to a clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:43 UTC GrantCommon Stock 2 $325.91 $651.82
Disclosure

SEC source: 0001104659-24-004906 · tm243653-1_4seq1.xml · nonDerivative · entry 5

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,397

F3 · shares: Represents settlement of shares of Common Stock issued in lieu of cash fees to which the Reporting Person was previously granted pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023 and inadvertently not previously issued due to a clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:45 UTC GrantCommon Stock 87 $186.10 $16,190.70
Disclosure

SEC source: 0001104659-24-004908 · tm243653-3_4seq1.xml · nonDerivative · entry 3

Broader Shelley G. · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,520

F3 · shares: Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:45 UTC GrantCommon Stock 8 $150.47 $1,203.76
Disclosure

SEC source: 0001104659-24-004908 · tm243653-3_4seq1.xml · nonDerivative · entry 2

Broader Shelley G. · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,433

F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:45 UTC GrantCommon Stock 2 $325.91 $651.82
Disclosure

SEC source: 0001104659-24-004908 · tm243653-3_4seq1.xml · nonDerivative · entry 1

Broader Shelley G. · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,425

F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:44 UTC
Sparks Charisse YChief Medical Officer
GrantCommon Stock 3 $150.47 $451.41
Disclosure

SEC source: 0001104659-24-004907 · tm243653-2_4seq1.xml · nonDerivative · entry 2

Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 898

F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023 relating to her prior service as a member of the Issuer's Board of Directors. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
January 16, 2024 Filed Jan 19, 2024 01:44 UTC
Sparks Charisse YChief Medical Officer
GrantCommon Stock 2 $325.91 $651.82
Disclosure

SEC source: 0001104659-24-004907 · tm243653-2_4seq1.xml · nonDerivative · entry 1

Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 895

F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023 relating to her prior service as a member of the Issuer's Board of Directors. Such shares were not previously issued due to an inadvertent clerical error.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 21:16 UTC
Curet MyriamDirector
GrantCommon Stock 1,384 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-129207 · tm2333651-2_4seq1.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,384

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in three equal annual installments on the first three anniversaries of the date of grant, subject to the Reporting Person's continued service on the board of directors of the Issuer through each such vesting date.

Read SEC document
October 17, 2023 Filed Oct 17, 2023 23:52 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,037 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001104659-23-109698 · tm2328548-7_4seq1.xml · derivative · entry 6

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,037 shares

Expires 2027-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
October 17, 2023 Filed Oct 17, 2023 23:52 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 963 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001104659-23-109698 · tm2328548-7_4seq1.xml · derivative · entry 5

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,037

Underlying: Common Stock · 963 shares

Expires 2027-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
October 17, 2023 Filed Oct 17, 2023 23:52 UTC Exercise / conversionCommon Stock 1,037 $0.94 $974.78
Disclosure

SEC source: 0001104659-23-109698 · tm2328548-7_4seq1.xml · nonDerivative · entry 3

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2023 Filed Oct 17, 2023 23:52 UTC Exercise / conversionCommon Stock 963 $0.94 $905.22
Disclosure

SEC source: 0001104659-23-109698 · tm2328548-7_4seq1.xml · nonDerivative · entry 2

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,063

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 23:48 UTC GrantCommon Stock 91 $150.47 $13,692.77
Disclosure

SEC source: 0001104659-23-109694 · tm2328548-3_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,240

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 23:52 UTC GrantCommon Stock 141 $150.47 $21,216.27
Disclosure

SEC source: 0001104659-23-109698 · tm2328548-7_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,100

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 23:52 UTC GrantCommon Stock 25 $150.47 $3,761.75
Disclosure

SEC source: 0001104659-23-109697 · tm2328548-6_4seq1.xml · nonDerivative · entry 1

Sparks Charisse Y · CIK 0001940873 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 893

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 23:50 UTC GrantCommon Stock 99 $150.47 $14,896.53
Disclosure

SEC source: 0001104659-23-109696 · tm2328548-5_4seq1.xml · nonDerivative · entry 1

Broader Shelley G. · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,423

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 23:49 UTC GrantCommon Stock 87 $150.47 $13,090.89
Disclosure

SEC source: 0001104659-23-109695 · tm2328548-4_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,395

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy

Read SEC document
October 13, 2023 Filed Oct 17, 2023 23:47 UTC GrantCommon Stock 99 $150.47 $14,896.53
Disclosure

SEC source: 0001104659-23-109692 · tm2328548-2_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,137

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 9,086 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 14

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 0

Underlying: Common Stock · 9,086 shares

Expires 2027-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 113,698 $0.00 Strike: $2.07 $0.00
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 13

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 0

Underlying: Common Stock · 113,698 shares

Expires 2024-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 63,490 $0.00 Strike: $10.38 $0.00
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 12

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 0

Underlying: Common Stock · 63,490 shares

Expires 2028-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionStock Option (Right to Buy) · Derivative 21,762 $0.00 Strike: $10.38 $0.00
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 11

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 0

Underlying: Common Stock · 21,762 shares

Expires 2028-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

F1 · ownership.nature: Securities held by the TPH 2022 LLC.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Tax withholdingCommon Stock 4,175 $147.78 $616,981.50
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 8

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 115,629

F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Tax withholdingCommon Stock 52,411 $148.02 $7,757,876.22
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 7

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 119,804

F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Tax withholdingCommon Stock 31,376 $147.88 $4,639,882.88
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 6

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 172,315

F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Tax withholdingCommon Stock 10,758 $147.88 $1,590,893.04
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 5

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 117,655

F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock.

F1 · ownership.nature: Securities held by the TPH 2022 LLC.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionCommon Stock 9,086 $0.94 $8,540.84
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 4

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 203,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionCommon Stock 113,698 $2.07 $235,354.86
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 3

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 194,605

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionCommon Stock 63,490 $10.38 $659,026.20
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 2

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 80,907

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
October 12, 2023 Filed Oct 16, 2023 23:53 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionCommon Stock 21,762 $10.38 $225,889.56
Disclosure

SEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 128,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Securities held by the TPH 2022 LLC.

Read SEC document
October 12, 2023 Filed Jan 24, 2024 21:32 UTC
Sparks Charisse YChief Medical Officer
PurchaseCommon Stock 100 $153.50 $15,350.00
Disclosure

SEC source: 0001104659-24-006280 · tm244034-1_4seq1.xml · nonDerivative · entry 1

Sparks Charisse Y · CIK 0001940873 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 998

Read SEC document
September 21, 2023 Filed Sep 25, 2023 22:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001104659-23-103610 · tm2326878-1_4seq1.xml · derivative · entry 3

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,037

Underlying: Common Stock · 2,000 shares

Expires 2027-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 22:30 UTC Exercise / conversionCommon Stock 2,000 $0.94 $1,880.00
Disclosure

SEC source: 0001104659-23-103610 · tm2326878-1_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,959

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 20:35 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001104659-23-101619 · tm2326320-1_4seq1.xml · derivative · entry 3

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,037

Underlying: Common Stock · 2,000 shares

Expires 2027-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 20:35 UTC Exercise / conversionCommon Stock 2,000 $0.94 $1,880.00
Disclosure

SEC source: 0001104659-23-101619 · tm2326320-1_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,959

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 08, 2023 Filed Sep 13, 2023 20:14 UTC
Herbert Timothy P.Director · CEO and President
SaleStock Option (Right to Buy) · Derivative 2,499 Not disclosed Strike: $227.53 Not disclosed
Disclosure

SEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 20

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 5,553

Underlying: Common Stock · 2,499 shares

Expires 2030-12-14

F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm.

F10 · derivative.exercise_date: The grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC.

Read SEC document
September 08, 2023 Filed Sep 13, 2023 20:14 UTC
Herbert Timothy P.Director · CEO and President
SaleStock Option (Right to Buy) · Derivative 11,745 Not disclosed Strike: $194.82 Not disclosed
Disclosure

SEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 19

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 26,100

Underlying: Common Stock · 11,745 shares

Expires 2030-12-14

F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm.

F9 · derivative.exercise_date: The grant of options to purchase 43,200 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.